Transfer of plasma samples for assay development in the patent application New approaches to Alzheimer's diagnosis
- Conditions
- F00Dementia in Alzheimer disease
- Registration Number
- DRKS00004628
- Lead Sponsor
- VR-Klinikum Essen, Kliniken und Institut der Universität Duisburg-Essen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
a) The study participant can understand the situation, the clinical trial and the consequences of taking part at the clinical trial and the participant is in position to give the consent;
b) the study participants signed and personally dated the consent before any test-specific action is taken;
c) age of the study participant is 50 years or older.
Exclusion Criteria
Health concerns against sampling blood as study-specific measure.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Development of immunological tests for human blood plasma for determining the concentration of Aß (1-40) and Aß (1-42) and for comparison.
- Secondary Outcome Measures
Name Time Method